Correlation Between Protagenic Therapeutics and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Protagenic Therapeutics and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagenic Therapeutics and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagenic Therapeutics and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Protagenic Therapeutics and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagenic Therapeutics with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagenic Therapeutics and Acrivon Therapeutics,.
Diversification Opportunities for Protagenic Therapeutics and Acrivon Therapeutics,
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Protagenic and Acrivon is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Protagenic Therapeutics and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Protagenic Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagenic Therapeutics are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Protagenic Therapeutics i.e., Protagenic Therapeutics and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between Protagenic Therapeutics and Acrivon Therapeutics,
Given the investment horizon of 90 days Protagenic Therapeutics is expected to generate 1.99 times more return on investment than Acrivon Therapeutics,. However, Protagenic Therapeutics is 1.99 times more volatile than Acrivon Therapeutics, Common. It trades about 0.17 of its potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about -0.08 per unit of risk. If you would invest 56.00 in Protagenic Therapeutics on August 29, 2024 and sell it today you would earn a total of 17.00 from holding Protagenic Therapeutics or generate 30.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Protagenic Therapeutics vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| Protagenic Therapeutics |
| Acrivon Therapeutics, |
Protagenic Therapeutics and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protagenic Therapeutics and Acrivon Therapeutics,
The main advantage of trading using opposite Protagenic Therapeutics and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagenic Therapeutics position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.| Protagenic Therapeutics vs. Sino Biopharmaceutical Ltd | Protagenic Therapeutics vs. Eledon Pharmaceuticals | Protagenic Therapeutics vs. Rezolute | Protagenic Therapeutics vs. XOMA Corporation |
| Acrivon Therapeutics, vs. Eliem Therapeutics | Acrivon Therapeutics, vs. Scpharmaceuticals | Acrivon Therapeutics, vs. Milestone Pharmaceuticals | Acrivon Therapeutics, vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |